Insider Transactions in Q4 2023 at Relay Therapeutics, Inc. (RLAY)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 27
2023
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
244
-0.08%
|
$2,684
$11.51 P/Share
|
|
Dec 27
2023
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
294
-0.2%
|
$3,234
$11.51 P/Share
|
|
Dec 27
2023
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
977
-0.42%
|
$10,747
$11.51 P/Share
|
|
Dec 27
2023
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
294
-0.23%
|
$3,234
$11.51 P/Share
|
|
Oct 30
2023
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
1,354
-0.43%
|
$8,124
$6.03 P/Share
|
|
Oct 30
2023
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,697
-1.16%
|
$10,182
$6.03 P/Share
|
|
Oct 30
2023
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
3,451
-1.45%
|
$20,706
$6.03 P/Share
|
|
Oct 30
2023
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,632
-1.24%
|
$9,792
$6.03 P/Share
|